CHILDREN'S DIMETAPP COLD & ALLERGY CHEWABLE TABLETS OTC
Generic Name and Formulations:
Brompheniramine maleate 1mg, phenylephrine HCl 2.5mg; per tab; alcohol-free; grape flavor.
Pfizer Consumer Healthcare
Indications for CHILDREN'S DIMETAPP COLD & ALLERGY CHEWABLE TABLETS:
Rhinorrhea, allergy symptoms, nasal congestion.
<6yrs: do not use. 6–11yrs: chew 2 tabs every 4 hours; max 6 doses/24 hours.
Children <6yrs old. During or within 14 days of MAOIs. For use as a sedative hypnotic.
Hypertension. Cardiovascular disease. Thyroid disease. Diabetes. Glaucoma. GI or GU obstruction. Asthma. Lower respiratory disorders. Pregnancy. Nursing mothers.
Antihistamine + sympathomimetic.
See Contraindications. Hypertensive crisis with MAOIs. β-blockers may increase pressor effects of sympathomimetics. Antihypertensives antagonized. Increased CNS effects with other CNS depressants. Avoid alcohol.
Drowsiness, anticholinergic effects, dizziness, nervousness, insomnia, excitability in children.
Syrup—4oz, 8oz (w. dosing cup)
Neurology Advisor Articles
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Serious Adverse Events Profile for Cladribine Confirmed With Extended Data
- Patients With Multiple Sclerosis Face Greater Infection Risk
- Ozanimod Reduces Severe Relapses in Multiple Sclerosis More Than Interferon Beta-1a
- Unintended Pregnancy Common in Women With Epilepsy
- Aggressive Blood Pressure Lowering in Intracerebral Hemorrhage May Be Harmful
- Risk of Opioid-Benzodiazepine Overlap Up for Dual Prescribing
- Minority Residents Experience Burdens Linked to Race/Ethnicity
- Tips Provided for Budgeting in Medical Residency